(Q68298891)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

A phase II study of taxol in patients with malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

1 reference

26 October 2022

1 reference

26 October 2022

3

P H Wiernik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

5

J P Dutcher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

A. I. Einzig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

H. Hochster

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

D. L. Trump

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

E. Garowski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

J. Sasloff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

T. J. Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673965

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1673965

26 October 2022

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

http://link.springer.com/content/pdf/10.1007/BF00194546.pdf

1 reference

http://link.springer.com/article/10.1007/BF00194546/fulltext.html

26 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00194546

26 October 2022

1 reference

Investigational New Drugs

26 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

59-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

Taxol stabilizes microtubules in mouse fibroblast cells

23 September 2019

cites work

1 reference

12 December 2020

Phase I trial of taxol given as a 3-hour infusion every 21 days

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of taxol

1 reference

12 December 2020

High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial

1 reference

12 December 2020

Phase I trial of taxol in patients with advanced cancer

1 reference

12 December 2020

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma

1 reference

12 December 2020

A phase II trial of taxol in metastatic melanoma

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Phase I study of taxol using a 5-day intermittent schedule

1 reference

12 December 2020

Taxol produces a predominantly sensory neuropathy

1 reference

12 December 2020

Promotion of microtubule assembly in vitro by taxol

1 reference

12 December 2020

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

12 December 2020

Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673965%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference